1 completed, 1 recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Combination drug: new trials by email Literature Review of Combination drug trials Research Report on Combination drug
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies DS3790a, Combination drug - Hematological Malignancies, B-cell Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | Recruiting | Daiichi Sankyo | 420 | 2026-01-16 | 2026-08-24 |
| Clopidogrel Aspirin Therapy (CAT) Versus Apixiban Aspirin Therapy (AAT) After Lower Limb Revascularization Combination drug - Ischemia, Anticoagulants | Phase 1 / Phase 2 | Completed | Mansoura University | 1536 | 2019-07-03 | 2022-07-19 |
Hematologic Neoplasms (1) · Ischemia (1) · Lymphoma, B-Cell (1)
Daiichi Sankyo (1) · Mansoura University (1)
Egypt (1) · France (1) · Italy (1) · Japan (1) · United States (1)
2025 (1)